NeuroPace (NPCE) Amortization of Deferred Charges (2020 - 2026)

NeuroPace (NPCE) recorded quarterly Amortization of Deferred Charges of $68000.0 in Q1 2026, down 71.31% quarter-over-quarter from $237000.0 in Q4 2025, and up 38.78% on a YoY basis from $49000.0 in Q1 2025.

NeuroPace (NPCE) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

NeuroPace's Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $68000.0 for Q1 2026.

  • In Q1 2026, Amortization of Deferred Charges rose 38.78% year-over-year to $68000.0; the TTM figure through Mar 2026 stood at $405000.0 (up 62.65% YoY), while the FY2025 annual figure was $237000.0, down 82.94% from the prior year.
  • Amortization of Deferred Charges was $68000.0 for Q1 2026 at NeuroPace, down from $237000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $689000.0 in Q4 2023 to a low of $49000.0 in Q1 2025.
  • Historically, Amortization of Deferred Charges has averaged $223214.3 across 5 years, with a median of $100000.0 in 2022.
  • The sharpest annual moves came in 2024 and 2026: Amortization of Deferred Charges sank 87.98% in 2024, then jumped 38.78% in 2026.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $655000.0 in 2022, then climbed by 5.19% to $689000.0 in 2023, then slumped by 85.49% to $100000.0 in 2024, then soared by 137.0% to $237000.0 in 2025, then plunged by 71.31% to $68000.0 in 2026.
  • The last three Amortization of Deferred Charges figures came in at $68000.0 (Q1 2026), $237000.0 (Q4 2025), and $100000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 NeuroPace 527.50 Mn 473.52 Mn 18.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 68,000.00
Mar 31, 2026 68,000.00
Dec 31, 2025 237,000.00
Dec 31, 2025 237,000.00
Jun 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 49,000.00
Mar 31, 2025 49,000.00
Sep 30, 2024 100,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 78,000.00
Mar 31, 2024 78,000.00
Dec 31, 2023 689,000.00
Dec 31, 2023 689,000.00
Sep 30, 2023 100,000.00
Sep 30, 2023 100,000.00
Jun 30, 2023 100,000.00
Jun 30, 2023 100,000.00